Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives
Giuseppe Gaetano Loscocco, Alessandro M. Vannucchi
Topics & Concepts
RuxolitinibMyelofibrosisMedicinePolycythemia veraEssential thrombocythemiaJanus kinaseJanus kinase 2DiscontinuationInternal medicineMyeloproliferative neoplasmThrombopoietin receptorMyeloproliferative DisordersOncologyImmunologyBiologyCytokineHaematopoiesisStem cellReceptorBone marrowThrombopoietinGeneticsMyeloproliferative Neoplasms: Diagnosis and TreatmentEosinophilic Disorders and SyndromesKruppel-like factors research